ASCO 2023 | Immunotherapy at ASCO 2023: updates in neoadjuvant and adjuvant therapy

Omid Hamid, MD, The Angeles Clinic and Research Institute, Los Angeles, CA, discusses key takeaways from the American Society of Clinical Oncology (ASCO) 2023 Annual Congress, including a greater understanding of checkpoint inhibitors in the neoadjuvant and adjuvant settings, as well as novel trial designs across different modalities. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.